Enovix (NASDAQ:ENVX - Get Free Report) had its price target dropped by research analysts at Canaccord Genuity Group from $10.00 to $2.50 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Canaccord Genuity Group's price target indicates a potential upside of 75.44% from the company's previous close.
Several other equities analysts also recently commented on ENVX. Bank of America reiterated a "neutral" rating and issued a $4.00 price objective on shares of Enovix in a research note on Monday, August 17th. Loop Capital raised Enovix to a "strong-buy" rating in a report on Monday, August 17th. Northland Securities set a $4.00 target price on Enovix in a research note on Tuesday, October 13th. B. Riley Financial lowered shares of Enovix from a "buy" rating to a "neutral" rating and reduced their target price for the company from $9.00 to $2.00 in a report on Friday. Finally, Oppenheimer cut shares of Enovix from an "outperform" rating to a "market perform" rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $7.25.
View Our Latest Research Report on Enovix
Enovix Trading Down 10.9%
Enovix stock traded down $0.17 during trading hours on Monday, hitting $1.43. The stock had a trading volume of 12,430,199 shares, compared to its average volume of 7,253,913. The stock has a market cap of $312.71 million, a price-to-earnings ratio of -1.95 and a beta of 2.34. The business's 50 day simple moving average is $2.23 and its 200-day simple moving average is $3.93. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46. Enovix has a one year low of $1.28 and a one year high of $9.19.
Enovix (NASDAQ:ENVX - Get Free Report) last announced its earnings results on Friday, November 13th. The company reported ($0.15) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.05. The business had revenue of $11.04 million during the quarter. Enovix had a negative net margin of 406.54% and a negative return on equity of 67.80%. On average, equities analysts predict that Enovix will post -0.79 EPS for the current fiscal year.
Hedge Funds Weigh In On Enovix
Hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Enovix during the second quarter worth about $100,054,000. Jump Financial LLC lifted its stake in Enovix by 185.1% in the 3rd quarter. Jump Financial LLC now owns 1,596,042 shares of the company's stock valued at $4,629,000 after buying an additional 1,036,189 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Enovix during the 2nd quarter worth $8,689,000. Bank of America Corp DE acquired a new stake in shares of Enovix in the second quarter valued at approximately $8,356,000. Finally, Refined Wealth Management grew its stake in shares of Enovix by 0.7% in the 3rd quarter. Refined Wealth Management now owns 850,768 shares of the company's stock valued at $2,467,000 after buying an additional 5,918 shares during the period. Institutional investors own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company's batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.